Millions of people have found a simultaneously grim yet welcome surprise in their mailboxes of late: rebate checks from their car insurance companies which find themselves paying out far fewer claims as a result of COVID-19 “stay at home” orders. While modest, these premium givebacks are, of course, welcome at a time of economic uncertainty.… Read More »
Vince Kuraitis Deven McGraw By DEVEN McGRAW and VINCE KURAITIS This post is part of the series “The Health Data Goldilocks Dilemma: Privacy? Sharing? Both?” In our initial blog post of February 20th, “For Your Radar – Huge Implications for Healthcare in Pending Privacy Legislation,” we broadly discussed six key issues for healthcare stakeholders in… Read More »
WASHINGTON — The House on Thursday passed a suite of health care bills that tied shoring up the Affordable Care Act to lowering drug prices, as Democrats tried to hold Republicans to their campaign promises to secure coverage for pre-existing medical conditions and rein in the cost of prescription medicine. But Democratic leaders appeared to… Read More »
The Trump administration is in early talks with House Speaker Nancy Pelosi about possible legislation to lower prescription drug costs, a White House official confirmed to CNBC.
Senators see a opening for legislation to eliminate unexpected massive medical bills after President Trump enthusiastically endorsed the idea this week, raising the possibility of bipartisan work on a topic marked in recent years by bitter divisiveness. Key senators indicated on Thursday that they hope to work in the coming months across party lines and… Read More »